Phase III Approval UpdatesAugust 16, 2021 0Clinical Trials Regulatory roundup: Sanofi/Regeneron, J&J and Eyenovia boost approval chances with Phase III updates
Servier, Pfizer and Debiopharm gather gainsAugust 13, 2021 0Clinical Trials Regulatory roundup: Servier, Pfizer and Debiopharm gather gains with oncology trial updates; Karyopharm poses a loss
